Published in Thromb Haemost on October 20, 2011
Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta. Front Physiol (2012) 1.04
Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects. Front Physiol (2014) 0.79
Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice. Cardiovasc Diabetol (2014) 0.77
Cultivation of Pichia pastoris carrying the scFv anti LDL (-) antibody fragment. Effect of preculture carbon source. Braz J Microbiol (2017) 0.77
Metabolic syndrome - Removing roadblocks to therapy: Antigenic immunotherapies. Mol Metab (2014) 0.76
A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach. Clin Exp Vaccine Res (2016) 0.75
Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity. World J Cardiol (2014) 0.75
Preparation of a liposomal delivery system and its in vitro release of rapamycin. Exp Ther Med (2015) 0.75
The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol (1996) 2.34
The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev (1997) 1.73
Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology (1995) 1.69
The impact and recovery of asteroid 2008 TC(3). Nature (2009) 1.60
Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem (2001) 1.59
Structural characterisation of the exopolysaccharide produced by Lactobacillus delbrückii subspecies bulgaricus rr grown in skimmed milk. Carbohydr Res (1993) 1.49
Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation (2006) 1.41
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun (2009) 1.36
Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J (2001) 1.31
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem (1990) 1.24
Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells. J Biol Chem (1988) 1.21
FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med (2000) 1.19
Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. J Clin Invest (1997) 1.18
Structure of the exopolysaccharide produced by Lactococcus lactis subspecies cremoris H414 grown in a defined medium or skimmed milk. Carbohydr Res (1992) 1.17
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv Drug Deliv Rev (2001) 1.17
Fate and effects of 4-chlorophenol and 2,4-dichlorophenol in marine plankton communities in experimental enclosures. Ecotoxicol Environ Saf (1984) 1.08
Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol (2004) 1.07
Hepatic and extrahepatic scavenger receptors: function in relation to disease. Arterioscler Thromb Vasc Biol (2000) 1.06
Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation (2005) 1.06
Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 1.05
Endotoxin stimulates glycogenolysis in the liver by means of intercellular communication. J Biol Chem (1988) 1.04
Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro. J Pharmacol Exp Ther (1996) 1.03
Eicosanoid production by rat cerebral endothelial cells: stimulation by lipopolysaccharide, interleukin-1 and interleukin-6. J Neuroimmunol (1995) 1.01
Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells. Thromb Res Suppl (1990) 1.01
Conditioned media of Kupffer and endothelial liver cells influence protein phosphorylation in parenchymal liver cells. Involvement of prostaglandins. Biochem J (1988) 1.00
Differential effects of regulatory T cells on the initiation and regression of atherosclerosis. Atherosclerosis (2011) 0.99
Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. Biochem J (1988) 0.97
New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun (1998) 0.96
Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data. Arterioscler Thromb Vasc Biol (2006) 0.93
Lymphocyte adhesion to brain capillary endothelial cells in vitro. J Neuroimmunol (1994) 0.92
Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res (2001) 0.92
Ligand size is a major determinant of high-affinity binding of fucose- and galactose-exposing (lipo)proteins by the hepatic fucose receptor. Biochem J (1994) 0.91
IgG subclass response to Helicobacter pylori in patients with chronic active gastritis and duodenal ulcer. Scand J Gastroenterol (1992) 0.90
Normative sexual behavior in children. Pediatrics (1991) 0.89
Seal vaccination success. Nature (1989) 0.89
Characterization in vitro of interaction of human apolipoprotein E-free high density lipoprotein with human hepatocytes. Arteriosclerosis (1990) 0.88
Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors. Mol Pharmacol (1998) 0.88
Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration. J Biol Chem (1996) 0.88
Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis (2009) 0.88
Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice. Cardiovasc Res (2005) 0.88
Interleukin-1 receptors on rat brain endothelial cells: a role in neuroimmune interaction? FASEB J (1996) 0.87
T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development. Int J Cardiol (2013) 0.87
Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo. Biochem J (1999) 0.86
Vaccination of harbour seals (Phoca vitulina) against phocid distemper with two different inactivated canine distemper virus (CDV) vaccines. Vaccine (1989) 0.84
Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis. J Pharmacol Exp Ther (1999) 0.84
Characterization of the interaction of acetylated LDL and oxidatively modified LDL with human liver parenchymal and Kupffer cells in culture. Arterioscler Thromb (1992) 0.84
Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator. Circulation (1997) 0.84
Lipoprotein receptors and atherogenic receptor-mediated mechanisms. Curr Opin Lipidol (1994) 0.82
Flow-through viscometer for use in the automated determination of hydrolytic enzyme activities: application in protease, amylase, and pectinase assays. Anal Biochem (1978) 0.82
Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages. FASEB J (1998) 0.82
Beta-migrating very-low-density lipoproteins and chylomicron remnants bind to rat liver hepatocytes at a low-density-lipoprotein-receptor-independent site (the remnant receptor). Biochem J (1995) 0.81
Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab (1996) 0.81
High-density lipoprotein and cerebral endothelial cells in vitro: interactions and transport. Biochem Pharmacol (1995) 0.80
Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator. Hepatology (1992) 0.80
Uptake and degradation of human low-density lipoprotein by human liver parenchymal and Kupffer cells in culture. Biochem J (1991) 0.80
Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA. Biochem J (1992) 0.80
An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation. Arterioscler Thromb Vasc Biol (2013) 0.79
Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol (1999) 0.78
Identification of an internalising peptide in differentiated Calu-3 cells by phage display technology; application to gene delivery to the airways. J Drug Target (2003) 0.77
The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats. Thromb Haemost (1997) 0.77
Transport of a hydrophilic compound into the cerebrospinal fluid during experimental allergic encephalomyelitis and after lipopolysaccharide administration. Pharm Res (1995) 0.77
Characterization of the low-density-lipoprotein-receptor-independent interaction of beta-very-low-density lipoprotein with rat and human parenchymal liver cells in vitro. Biochem J (1992) 0.77
Complete down-regulation of low-density lipoprotein receptor activity in human liver parenchymal cells by beta-very-low-density lipoprotein. FEBS Lett (1991) 0.77
Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver. Ann N Y Acad Sci (1992) 0.76
Design and synthesis of a multivalent homing device for targeting to murine CD22. Bioorg Med Chem (2001) 0.76
Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells. Thromb Haemost (1995) 0.76
A structure-function study of ligand recognition by CD22beta. J Biol Chem (2001) 0.76
Lymphocyte and macrophage populations in the liver. Hepatogastroenterology (1996) 0.76
Characterization of the scavenger receptor on bovine cerebral endothelial cells in vitro. J Neurochem (1993) 0.76
[Neuroleptic malignant syndrome in users of risperidone]. Ned Tijdschr Geneeskd (2005) 0.75
Effect of cyclosporin A, cyclophosphamide on graft versus host reactions. Cell Biol Int Rep (1984) 0.75
Disturbance-free skin electrodes for persons during exercise. Med Biol Eng (1966) 0.75
Graft versus host reaction in the rat: effect of cyclosporin A and cyclophosphamide on lymphocyte subsets involved in GvHR. Adv Exp Med Biol (1985) 0.75
Characterization of the binding of urokinase-type plasminogen activator to the asialoglycoprotein receptor. Thromb Haemost (2002) 0.75
[Recording of fetal heart action]. Ned Tijdschr Geneeskd (1965) 0.75
Ligand specificity of the LDL-receptor related protein. Z Gastroenterol (1996) 0.75
Hepatocellular localisation of biosynthesis of vitronectin. Characterisation of the primary structure of rat vitronectin. Biochem Mol Biol Int (1995) 0.75
Zonal distribution of receptor binding of trypsin-activated alpha 2-macroglobulin, alpha 2-macroglobulin receptor-associated protein, lactoferrin and transferrin on rat liver parenchymal cells. Biochim Biophys Acta (1995) 0.75
Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein. Mol Pharmacol (1994) 0.75
Cardiac output monitoring in intensive care patients by radial artery pressure waveform analysis. Conf Proc IEEE Eng Med Biol Soc (2004) 0.75
[Fetal electrocardiogram and cardiotachogram during delivery (using skull electrodes and a computer)]. Ned Tijdschr Geneeskd (1965) 0.75
[New perspectives in fetal electrocardiography. Use of a recording device]. Ned Tijdschr Geneeskd (1965) 0.75
Development of marine periphyton under mercury stress in a controlled ecosystem experiment. Bull Environ Contam Toxicol (1980) 0.75
Fate and effects of mercury in marine plankton communities in experimental enclosures. Ecotoxicol Environ Saf (1981) 0.75
The role of mast cells in atherosclerosis. Hamostaseologie (2014) 0.75
Fate and effects of 3,4-dichloroaniline (DCA) in marine plankton communities in experimental enclosures. Ecotoxicol Environ Saf (1984) 0.75